North Miami, FL 10/16/18 — Carevive Systems (https://www.carevive.com) announced today that Mordecai Kramer, MBA has joined the company as Vice President, Data Generation & Outcomes, Life Sciences. In this role, Mordecai will engage with life science companies seeking to generate data from Carevive’s unique patient-reported outcomes (PRO) platform, which will offer them new insights about clinical outcomes within target patient populations.
Mordecai possesses more than 20 years of life science experience in a variety of senior business and leadership roles. He most recently served as Executive Director of Business Development at Baim Institute (formerly the Harvard Clinical Research Institute) where he orchestrated nearly $500MM in complex and consultative research engagements with life science companies across the spectrum of clinical research and therapy development.
In doing so, Mordecai has become known in the life science community for bringing together industry sponsors, academia and cross-functional operations teams to answer many important and data-driven research questions that have improved patient health and quality of life. Many of these results have led to and supported FDA approval, enhanced evidence-based practice and have been published in leading peer-reviewed journals.
“It is an honor to join Carevive. The energy and commitment that the team brings to improving cancer care are truly inspirational. I am excited about helping our life science sponsors to access the Carevive platform and seeing how our data will benefit patients, providers, and industry alike.”
Carevive’s Chief Executive Officer, Madelyn Herzfeld welcomes Mordecai to the Carevive team. “I look forward to the value that Mordecai will bring to growing our portfolio of projects with life science companies, further demonstrating the value of our technology through the novel insights we offer about the cancer patient experience in the real world.”
Carevive is a health technology company focusing on care management and patient engagement solutions to improve the quality of life and clinical outcomes of cancer patients. Our platform analyzes clinical and patient-reported data, and the latest clinical guidelines, to offer evidence-based recommendations to clinicians so they can improve patient outcomes from cancer treatment. Our health system customers often partner with us and life science companies to use our insights of the real-world cancer patient experience to inform the drug development process. Carevive has partnered with over 35 academic and community cancer programs and 8 oncology-focused life science companies. For more information, please visit www.carevive.com or follow us @carevive.